Alapfogalmak
Adaptive deep brain stimulation using ϵ-Neural Thompson Sampling improves treatment efficacy and energy efficiency in Parkinson's disease.
Statisztikák
RL approaches require significant training data and resources.
CMAB leads to better sample efficiency compared to RL.
ϵ-NeuralTS outperforms existing cDBS methods and baselines.